Matches in SemOpenAlex for { <https://semopenalex.org/work/W3120878331> ?p ?o ?g. }
- W3120878331 endingPage "901" @default.
- W3120878331 startingPage "891" @default.
- W3120878331 abstract "There is an urgent need for novel therapeutic approaches to treat Alzheimer's disease (AD) with the ability to both alleviate the clinical symptoms and halt the progression of the disease. AD is characterized by the accumulation of amyloid-β (Aβ) peptides which are generated through the sequential proteolytic cleavage of the amyloid precursor protein (APP). Previous studies reported that Mint2, a neuronal adaptor protein binding both APP and the γ-secretase complex, affects APP processing and formation of pathogenic Aβ. However, there have been contradicting results concerning whether Mint2 has a facilitative or suppressive effect on Aβ generation. Herein, we deciphered the APP-Mint2 protein-protein interaction (PPI) via extensive probing of both backbone H-bond and side-chain interactions. We also developed a proteolytically stable, high-affinity peptide targeting the APP-Mint2 interaction. We found that both an APP binding-deficient Mint2 variant and a cell-permeable PPI inhibitor significantly reduced Aβ42 levels in a neuronal in vitro model of AD. Together, these findings demonstrate a facilitative role of Mint2 in Aβ formation, and the combination of genetic and pharmacological approaches suggests that targeting Mint2 is a promising therapeutic strategy to reduce pathogenic Aβ levels." @default.
- W3120878331 created "2021-01-18" @default.
- W3120878331 creator A5002178330 @default.
- W3120878331 creator A5008546272 @default.
- W3120878331 creator A5023025306 @default.
- W3120878331 creator A5035890430 @default.
- W3120878331 creator A5042747387 @default.
- W3120878331 creator A5045372915 @default.
- W3120878331 creator A5048035528 @default.
- W3120878331 creator A5050777452 @default.
- W3120878331 creator A5060992391 @default.
- W3120878331 creator A5062421025 @default.
- W3120878331 creator A5072904379 @default.
- W3120878331 creator A5078601301 @default.
- W3120878331 creator A5082697577 @default.
- W3120878331 creator A5087510303 @default.
- W3120878331 creator A5091728466 @default.
- W3120878331 date "2021-01-05" @default.
- W3120878331 modified "2023-10-11" @default.
- W3120878331 title "Targeting the APP-Mint2 Protein–Protein Interaction with a Peptide-Based Inhibitor Reduces Amyloid-β Formation" @default.
- W3120878331 cites W1485287758 @default.
- W3120878331 cites W1754645121 @default.
- W3120878331 cites W1943916690 @default.
- W3120878331 cites W1965903509 @default.
- W3120878331 cites W1971780683 @default.
- W3120878331 cites W1974925207 @default.
- W3120878331 cites W1977428099 @default.
- W3120878331 cites W1978999164 @default.
- W3120878331 cites W1980825524 @default.
- W3120878331 cites W1986730778 @default.
- W3120878331 cites W1992285081 @default.
- W3120878331 cites W1999138945 @default.
- W3120878331 cites W2000644111 @default.
- W3120878331 cites W2005739560 @default.
- W3120878331 cites W2011680158 @default.
- W3120878331 cites W2017837319 @default.
- W3120878331 cites W2024351982 @default.
- W3120878331 cites W2030892371 @default.
- W3120878331 cites W2031615571 @default.
- W3120878331 cites W2039735500 @default.
- W3120878331 cites W2041459336 @default.
- W3120878331 cites W2050878447 @default.
- W3120878331 cites W2051145405 @default.
- W3120878331 cites W2062253976 @default.
- W3120878331 cites W2068858946 @default.
- W3120878331 cites W2069506919 @default.
- W3120878331 cites W2074575643 @default.
- W3120878331 cites W2074848000 @default.
- W3120878331 cites W2077009902 @default.
- W3120878331 cites W2079211667 @default.
- W3120878331 cites W2080616775 @default.
- W3120878331 cites W2083081567 @default.
- W3120878331 cites W2091316116 @default.
- W3120878331 cites W2101804995 @default.
- W3120878331 cites W2103087982 @default.
- W3120878331 cites W2112389863 @default.
- W3120878331 cites W2115963048 @default.
- W3120878331 cites W2121974357 @default.
- W3120878331 cites W2123650819 @default.
- W3120878331 cites W2129085204 @default.
- W3120878331 cites W2138784057 @default.
- W3120878331 cites W2151680754 @default.
- W3120878331 cites W2157860584 @default.
- W3120878331 cites W2162051767 @default.
- W3120878331 cites W2165691530 @default.
- W3120878331 cites W2167953455 @default.
- W3120878331 cites W2200418872 @default.
- W3120878331 cites W2329336071 @default.
- W3120878331 cites W2588859353 @default.
- W3120878331 cites W2599851926 @default.
- W3120878331 cites W2612541225 @default.
- W3120878331 cites W2760285987 @default.
- W3120878331 cites W2787612390 @default.
- W3120878331 cites W2907547898 @default.
- W3120878331 cites W2951064874 @default.
- W3120878331 cites W3007594181 @default.
- W3120878331 cites W4210475127 @default.
- W3120878331 cites W4211028926 @default.
- W3120878331 doi "https://doi.org/10.1021/jacs.0c10696" @default.
- W3120878331 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8176898" @default.
- W3120878331 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33398998" @default.
- W3120878331 hasPublicationYear "2021" @default.
- W3120878331 type Work @default.
- W3120878331 sameAs 3120878331 @default.
- W3120878331 citedByCount "15" @default.
- W3120878331 countsByYear W31208783312021 @default.
- W3120878331 countsByYear W31208783312022 @default.
- W3120878331 countsByYear W31208783312023 @default.
- W3120878331 crossrefType "journal-article" @default.
- W3120878331 hasAuthorship W3120878331A5002178330 @default.
- W3120878331 hasAuthorship W3120878331A5008546272 @default.
- W3120878331 hasAuthorship W3120878331A5023025306 @default.
- W3120878331 hasAuthorship W3120878331A5035890430 @default.
- W3120878331 hasAuthorship W3120878331A5042747387 @default.
- W3120878331 hasAuthorship W3120878331A5045372915 @default.
- W3120878331 hasAuthorship W3120878331A5048035528 @default.
- W3120878331 hasAuthorship W3120878331A5050777452 @default.
- W3120878331 hasAuthorship W3120878331A5060992391 @default.